AURKA and cancer: Compound <b>15</b> degrades AURKA with low DC<sub>50</sub> value of 2.05 nM, which is 77-fold and 21-fold more selective toward AURKB and TTK and has an EC<sub>50</sub> value of 39 nM against cancer MV4-11 cells.